Is The Journey Knee The Worst TKA On The Market?

Quote






Regardless of opinion on JII, how is everyone going to feel once it starts getting sold via Syncera. Syncera is starting to go live in several accounts across the country. Wonder how the repless programs are going at Depuy, Zimmer, Biomet, & Stryker? Oh wait, they don't offer a repless program...
 






Anonymous said:
I agree with your premise. Most Orthopaedic surgeons are typical and are ok with giving a typical implant and doing typical work in the OR.

And most patients getting TKAs need more deformity correction than J2 can offer w/o the bells and whistles.

But, there are patients with higher demands that will benefit from J2. Period. It is our job to find those surgeons wanting to please those patients and show them J2. VERY GOOD DATA is accumulating...
Click to expand...

When the data comes, and when I get paid more for selling it over current knees, I will jump on board.
 


















Hey ,,,,,,,,,,,,,,,,,, why is the Journey Knee a bad knee............. watched a video of a DR. Cherre Do one in State College, PA. Went pretty well I thought. Who is his Rep????
 






It most likely is not a bad knee. It is likely what other mfgs would do if they were not concerned about inventory as much as clinical performance. Short story, it is in effect a medial pivot knee which has been around for years with good data. Most mfgs are not interested in the kind of inventory it takes to produce this knee. Asymetric, tibias, femurs, inserts. Fact of the matter is J2 comes closest to replicating normal knee kinematics of any replacement on the market. Attune and Persona are trying to sell the same story and they are good products but dont go as far with the equation, in my humble semi educated opinion.
 












Anonymous said:
It most likely is not a bad knee. It is likely what other mfgs would do if they were not concerned about inventory as much as clinical performance. Short story, it is in effect a medial pivot knee which has been around for years with good data. Most mfgs are not interested in the kind of inventory it takes to produce this knee. Asymetric, tibias, femurs, inserts. Fact of the matter is J2 comes closest to replicating normal knee kinematics of any replacement on the market. Attune and Persona are trying to sell the same story and they are good products but dont go as far with the equation, in my humble semi educated opinion.
Click to expand...

Wrong. XP?
 






Anonymous said:
It most likely is not a bad knee. It is likely what other mfgs would do if they were not concerned about inventory as much as clinical performance. Short story, it is in effect a medial pivot knee which has been around for years with good data. Most mfgs are not interested in the kind of inventory it takes to produce this knee. Asymetric, tibias, femurs, inserts. Fact of the matter is J2 comes closest to replicating normal knee kinematics of any replacement on the market. Attune and Persona are trying to sell the same story and they are good products but dont go as far with the equation, in my humble semi educated opinion.
Click to expand...

Conformis solves all of these problems.
 






Anonymous said:
Regardless of opinion on JII, how is everyone going to feel once it starts getting sold via Syncera. Syncera is starting to go live in several accounts across the country. Wonder how the repless programs are going at Depuy, Zimmer, Biomet, & Stryker? Oh wait, they don't offer a repless program...
Click to expand...

Stryker can't wait to get rid of their reps--why do you think they have purchased Mako and cut commission? One is a short term plan to reduce expenses but the long term--10 years out--is no reps.
 




































The issue of tibial component fracture was related to the Journey Uni several years ago, not the primary. All things considered there are worse issues surrounding a number of implant designs past and present.
 






Top Bottom
Back
Quote